Results 181 to 190 of about 59,841 (273)
Peptide‐enabled nanoplatforms offer multifunctional strategies for the treatment and diagnosis of malaria and leishmaniasis. Liposomal, polymeric, and metallic nanocarriers, together with cell‐penetrating peptides and parasite‐derived mimotopes, can improve targeted drug delivery, stability, bioavailability, and intracellular localization.
Christian S. Carnero Canales +7 more
wiley +1 more source
The role of immune cells in Hantaan-induced hemorrhagic fever with renal syndrome. [PDF]
Su L +5 more
europepmc +1 more source
Editorial: AI-driven advances in immunology and immune-mediated disorders. [PDF]
Pizzagalli DU, Porta G, Wortel IMN.
europepmc +1 more source
Antigen-specific type 1 regulatory T cell responses shape immunity and disease tolerance in human malaria. [PDF]
Brockmann L.
europepmc +1 more source
Editorial: SARS-CoV-2 vaccines beyond the pandemic era, volume II. [PDF]
Bao S, Rahimi F, Yorsaeng R.
europepmc +1 more source
The challenge of cell death switching in inflammasome-targeted therapies for bacterial and viral infections. [PDF]
Li Y, Lv D, Xie Q, Qi Y, Qi X.
europepmc +1 more source
Dangerous liaisons: Candidalysin and myeloid cells in candidiasis. [PDF]
Gu ZQ, Chen YY, Tsai YH.
europepmc +1 more source
The kynurenine pathway in RNA virus infection: immunometabolic control of antiviral defense and viral persistence. [PDF]
Calderón-Sandate DN +10 more
europepmc +1 more source

